P-6308
Current Oncology | 2026
Real-world outcomes of axicabtagene ciloleucel for treatment of relapsed or refractory large B-cell lymphoma in Canada.
Lemieux C, Kuruvilla J, Shafey M, Davison K, Paulson K, Li SZL, Billen L, Nissen F, Wang HL, Kim JJ, Lee G, Hu ZH, Logan B, Feng Z, Pasquini MC, Hay K
PubMed
PMID: 41744849
CIBMTR Study #: CIBMTR_NA